Complex | |
AACDB_ID: | 3571 |
PDBID: | 7D6Y |
Chains: | B_A |
Organism: | Homo sapiens |
Method: | XRD |
Resolution (Å): | 1.67 |
Reference: | Not available or To be published |
Antibody | |
Antibody: | 1C5 VHH |
Antibody mutation: | No |
INN (Clinical Trial): | |
Antigen | |
Antigen: | Eukaryotic translation initiation factor 4E |
Antigen mutation: | No |
Durg Target: | P06730 |
Antibody
Chain: B
Mutation: NULL
>7D6Y_B|Chain B|VH Domain (1C5)|Homo sapiens (9606) MSEVQLVESGGGLVQPGGSLRLSSAISGFSISSTSIDWVRQAPGKGLEWVARISPSSGSTSYADSVKGRFTISADTSKNTVYLQMNSLRAEDTAVYYTGRVAKDLNSSSPSFVVNTYSSFGFDYRGQGTLVTVSSGAAEQKLISEEDLNGAAAFEHHHHHH |
Antigen
Chain: A
Mutation: NULL
>7D6Y_A|Chain A|Eukaryotic translation initiation factor 4E|Homo sapiens (9606) MATVEPETTPTPNPPTTEEEKTESNQEVANPEHYIKHPLQNRWALWFFKNDKSKTWQANLRLISKFDTVEDFWALYNHIQLSSNLMPGCDYSLFKDGIEPMWEDEKNKRGGRWLITLNKQQRRSDLDRFWLETLLCLIGESFDDYSDDVCGAVVNVRAKGDKIAIWTTECENREAVTHIGRVYKERLGLPPKIVIGYQSHADTATKSGSTTKNRFVV |
Interaction
1、Solvent accessible surface areas (SASA) were calculated (Naccess V2.1.1) for each residue in antibody and antigen, respectively. The residues with SASA loss in binding of more than 1Å2 were classified as interacting residues.
Interacting residues (ΔSASA based)
B: GLU2 VAL3 GLN4 LEU5 ALA101 LYS102 ASP103 LEU104 THR115 TYR116 SER118 PHE119 PHE121 ASP122 TYR123 ARG124 GLY125 GLN126 A: GLU32 HIS33 TYR34 ILE35 HIS37 PRO38 LEU39 VAL69 GLU70 TRP73 ALA74 TYR76 ASN77 LEU81 LEU131 GLU132 LEU135 ILE138 GLY139 GLU140 ARG186 |
2、We defined interacting paratope-epitope residues by a distance cutoff of < 5Å . Two amino acids are considered as interacting residues if they have at least one atom within a distance of 5 Å from any atom.
Interacting residues (Atom distance based)